Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Assessing Interventions of Diet in IBD [NA]
A McMaster University-led clinical trial is recruiting to evaluate the effects of dietary interventions on inflammatory bowel disease, inclu…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Enabling Microbiomics- Driven Personalized Nutrition
A Mayo Clinic-led clinical trial is exploring microbiome-driven personalized nutrition for inflammatory bowel disease and irritable bowel sy…
-
EMA approval · 2025-06-24EMA Authorised: Zessly (infliximab) — Sandoz GmbH
EMA authorised Zessly (infliximab) from Sandoz GmbH as a biosimilar for treatment of several inflammatory diseases, including rheumatoid art…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis [Phase 4]
A Phase 4 trial (EFFICACI) comparing intravenous infliximab versus vedolizumab in ulcerative colitis patients after failure of subcutaneous …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating D-2570 in adults with moderately to severely active ulcerative colitis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation [NA]
Clinical trial update evaluating functional outcomes in ulcerative colitis patients with ileal pouch-anal anastomosis treated with high inte…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]
A Phase 2 study evaluating OSE-127 versus placebo in moderate to severe active ulcerative colitis has completed.
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis [Phase 3]
Phase 3 clinical trial evaluating and comparing medical rescue strategies for patients with steroid-refractory acute severe ulcerative colit…
-
FDA approval · 2025-06-17FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MESALAMINE from Actavis Pharma, Inc., resulting in approval of a supplemental to the approved ge…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® [Phase 3]
Phase 3 trial evaluating the efficacy, safety, and immunogenicity of the proposed vedolizumab biosimilar PB016 compared with Entyvio. The st…
-
FDA approval · 2025-06-13FDA Approved: AZATHIOPRINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for azathioprine from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Spiritual Needs of European Patients With Inflammatory Bowel Disease and Their Caregivers
This clinical trial update describes a study funded by the University of Padova examining the spiritual needs of European patients with infl…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD) [EARLY_Phase 1]
The early-phase trial of Serum Bovine Immunoglobulin (SBI) in children and young adults with inflammatory bowel disease has been terminated.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy [Phase 1, Phase 2]
Pilot and feasibility phase 1/2 trial investigating 2'-fucosyllactose as a dietary supplement in inflammatory bowel disease patients on stab…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Treatment of UC With Novel Therapeutics [Phase 2]
Phase 2 clinical trial investigating novel therapeutics for ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Personalized Anti-Inflammatory Fibres in Ulcerative Colitis [NA]
A University of Alberta-sponsored clinical trial investigating personalized anti-inflammatory fibres for Ulcerative Colitis is currently rec…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis [NA]
This clinical trial update reports on a completed study evaluating the use of intestinal ultrasound to assess pouchitis and other outcomes a…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). [Phase 4]
Phase 4 trial evaluating prevention of recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. The study w…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis
A non-interventional pilot trial examining the role of gut flora in ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up [NA]
A terminated clinical trial investigated whether detecting herpesvirus DNA (CMV, EBV, HHV-6, and HSV) in colonic tissue influences ulcerativ…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer-sponsored trial of infliximab biosimilar 3 in rheumatoid arthritis, ulcerative colitis, Crohn's disease, and psoriasis has completed …
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis
A ClinicalTrials.gov entry for a study to identify predictors and biomarkers of response to Ozanimod in ulcerative colitis has been withdraw…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
This clinical trial update describes the development of a screening tool to identify spondyloarthritis in patients with inflammatory bowel d…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study
A multicenter retrospective study assesses the efficacy of subcutaneous infliximab in acute severe ulcerative colitis. The trial status is n…